These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 1872016

  • 1. Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule.
    Christenson B, Böttiger M.
    Vaccine; 1991 May; 9(5):326-9. PubMed ID: 1872016
    [Abstract] [Full Text] [Related]

  • 2. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, Hurni W, Nalin DR.
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [Abstract] [Full Text] [Related]

  • 3. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B, Böttiger M.
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [Abstract] [Full Text] [Related]

  • 4. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
    Coté TR, Sivertson D, Horan JM, Lindegren ML, Dwyer DM.
    Public Health Rep; 1993 Apr 25; 108(4):431-5. PubMed ID: 8341775
    [Abstract] [Full Text] [Related]

  • 6. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
    Pauksen K, Duraj V, Ljungman P, Sjölin J, Oberg G, Lönnerholm G, Fridell E, Smedmyr B, Simonsson B.
    Bone Marrow Transplant; 1992 Jun 25; 9(6):427-32. PubMed ID: 1628126
    [Abstract] [Full Text] [Related]

  • 7. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH, Saracen CL, Peter G.
    Pediatrics; 1994 Oct 25; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [Abstract] [Full Text] [Related]

  • 8. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland.
    Davidkin I, Peltola H, Leinikki P, Valle M.
    Vaccine; 2000 Jul 15; 18(27):3106-12. PubMed ID: 10856790
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of live attenuated varicella vaccine (Oka-RIT strain) and combined varicella and MMR vaccination in 13-17-month-old children.
    Vesikari T, Ohrling A, Baer M, Delem A, Bogaerts H, André FE.
    Acta Paediatr Scand; 1991 Nov 15; 80(11):1051-7. PubMed ID: 1661057
    [Abstract] [Full Text] [Related]

  • 10. Vaccination against measles, mumps and rubella (MMR): a comparison between the antibody responses at the ages of 18 months and 12 years and between different methods of antibody titration.
    Christenson B, Böttiger M.
    J Biol Stand; 1985 Apr 15; 13(2):167-72. PubMed ID: 3997899
    [Abstract] [Full Text] [Related]

  • 11. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
    King GE, Markowitz LE, Heath J, Redd SC, Coleman S, Bellini WJ, Sievert A.
    JAMA; 1996 Mar 06; 275(9):704-7. PubMed ID: 8594268
    [Abstract] [Full Text] [Related]

  • 12. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds.
    Krober MS, Stracener CE, Bass JW.
    JAMA; 1991 Apr 24; 265(16):2095-6. PubMed ID: 2013930
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
    Glikmann G, Petersen I, Mordhorst CH.
    Dan Med Bull; 1988 Apr 24; 35(2):185-7. PubMed ID: 3359817
    [Abstract] [Full Text] [Related]

  • 14. Measles, mumps and rubella immunisation in children at risk of infection with human immunodeficiency virus.
    Molyneaux PJ, Mok JY, Burns SM, Yap PL.
    J Infect; 1993 Nov 24; 27(3):251-3. PubMed ID: 8308316
    [Abstract] [Full Text] [Related]

  • 15. [Changes in measles, mumps and rubella (MMR) immunity until the year of 2002 after the introduction of MMR vaccination].
    Rønne T, Trier H.
    Ugeskr Laeger; 1992 Jul 13; 154(29):2014-8. PubMed ID: 1509567
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of mumps antibodies after measles-mumps-rubella (MMR) vaccines.
    Ozaki K, Kuno-Sakai H, Kimura M.
    Tokai J Exp Clin Med; 1987 Dec 13; 12(5-6):305-11. PubMed ID: 3508655
    [Abstract] [Full Text] [Related]

  • 17. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
    Pisón Garcés FJ, Galbe Sánchez-Ventura J, Arcauz Eguren P, Aguirre y Dabán C, Mengual Gil J, Larrad Mur L.
    Aten Primaria; 1995 Mar 15; 15(4):235-7. PubMed ID: 7703334
    [Abstract] [Full Text] [Related]

  • 18. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A, Gerike E.
    Vaccine; 2000 Jan 31; 18(14):1382-92. PubMed ID: 10618536
    [Abstract] [Full Text] [Related]

  • 19. Response to measles-mumps-rubella vaccine in children on dialysis.
    Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte HJ.
    Pediatr Nephrol; 1992 Mar 31; 6(2):187-9. PubMed ID: 1571219
    [Abstract] [Full Text] [Related]

  • 20. Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.
    Böttiger M, Christenson B, Romanus V, Taranger J, Strandell A.
    Br Med J (Clin Res Ed); 1987 Nov 14; 295(6608):1264-7. PubMed ID: 3120971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.